Inovalon Achieves NCQA HEDIS® Measure Certification for Its 22nd Consecutive Year
Inovalon’s QSI-XL® Cloud Software Solution Empowers More Than 80% of the Nation’s Clinical Outcomes Measurement AnalyticsBOWIE, Md., Sept. 08, 2022...
Inovalon’s QSI-XL® Cloud Software Solution Empowers More Than 80% of the Nation’s Clinical Outcomes Measurement AnalyticsBOWIE, Md., Sept. 08, 2022...
Late-breaking Dupixent® (dupilumab) data at ERS 2022 show consistent efficacy and safety profile for up to two years in children...
DENVER, Sept. 02, 2022 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV) will release its 2022 fiscal fourth quarter...
Broad equity incentive agreement established with Pacific Medical, Inc. including initial equity purchase Favorable initial progress on establishing substantive distribution...
Former Zelis and Sapphire Digital Executive Brings a Proven Track Record of Driving Growth and Profitability at ScaleMINNEAPOLIS, Aug. 23,...
Arcutis Cares provides ZORYVE™ (roflumilast) cream 0.3% at no cost for financially eligible individuals who are uninsured or have Medicaid...
Signs Definitive Agreement to Acquire Standard BariatricsWAYNE, Pa., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading...
VANCOUVER, British Columbia, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT) (OTCPink:RQHTF) (FSE:MHN2), a rapidly growing global...
Conference Call Scheduled for Today at 8:30 a.m. Eastern TimeBERKELEY HEIGHTS, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) -- CorMedix Inc....
Almost half of Latina women are uninsured, nearly twice the national averageWASHINGTON, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Almost one...
SAN FRANCISCO, July 14, 2022 /PRNewswire/ -- Canvas Medical, the EMR that enables clinicians and developers to power the future...
WASHINGTON, July 14, 2022 /PRNewswire/ -- Guidehouse, a leading global provider of consulting services to public sector and commercial clients,...
ORANGE, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Alignment Healthcare (NASDAQ: ALHC), a tech-enabled Medicare Advantage company, today announced more details...
Dupixent®(dupilumab) Phase 3 trial shows positive results in children 1 to 11 years of age with eosinophilic esophagitis First and...